CRPS

AMD Showcases AEWIN High-Density Edge Computing Server at Embedded World 2024

Retrieved on: 
Tuesday, April 2, 2024
DTLS, SSL/TLS, OS, QAT, IPMI, CRPS, Total cost, Memory, Embedded, RAID, Common, NVM Express, DDR5, PCI Express, AI, BMC, OCP, Solid-state drive, AMD, IPsec, TDP, CPU, Video game

TAIPEI, April 2, 2024 /PRNewswire/ -- AEWIN is glad to share with you that our High-Density Edge Computing Server, BAS-6101A, powered by Single AMD Zen4 Genoa or Zen4c Bergamo CPU is selected is displayed by AMD at Embedded World 2024.

Key Points: 
  • TAIPEI, April 2, 2024 /PRNewswire/ -- AEWIN is glad to share with you that our High-Density Edge Computing Server, BAS-6101A, powered by Single AMD Zen4 Genoa or Zen4c Bergamo CPU is selected is displayed by AMD at Embedded World 2024.
  • The BAS-6101A supports the latest AMD Bergamo CPU with up to 128 cores (~100% increased) and 400W TDP (~28% increased) to enable the extreme computing power pursued in the market.
  • With its short-depth design of 600mm for easy deployment at the edge, the system is suitable for diverse Edge AI applications.
  • Learn more about AEWIN BAS-6101A at AMD's booth at Embedded World 2024 or contact AEWIN sales at any time!

Delta Demonstrates Digital Twin Developed on NVIDIA Omniverse and Its Own Energy-efficient AI Server Power and Infrastructure Solutions at NVIDIA GTC

Retrieved on: 
Wednesday, March 20, 2024
SD-WAN, GTC, Vapor, GPU, CRPS, SAN, Common, AI, Delta, BBU, San Jose Convention Center, NVIDIA, Nvidia Omniverse, Cryptocurrency

Mark Ko, Delta's Vice Chairman, said, "We are honored to be the only power and thermal management solutions provider at NVIDIA GTC 2024, where we will showcase the NVIDIA Omniverse-powered digital twin we have developed, which underscores our superior expertise in next-generation electronics manufacturing.

Key Points: 
  • Mark Ko, Delta's Vice Chairman, said, "We are honored to be the only power and thermal management solutions provider at NVIDIA GTC 2024, where we will showcase the NVIDIA Omniverse-powered digital twin we have developed, which underscores our superior expertise in next-generation electronics manufacturing.
  • We look forward to helping transcend the boundaries of energy efficiency in the AI realm using the latest technologies."
  • By developing its digital platform on NVIDIA Omniverse, Delta can virtually link specific production lines and aggregate data from a diverse range of equipment and systems to create a digital twin of its operations.
  • At NVIDIA GTC, in addition to the NVIDIA Omniverse-based digital twin, which Delta applies to specific production lines, the Company is also presenting an integrated Open Rack Version 3 (ORV3) solution for AI server infrastructure with server power supplies boasting energy efficiency as high as 97.5%.

AEWIN SCB-1942 Flagship Appliance, Powered by Dual Intel 5th Gen Xeon Scalable Processors

Retrieved on: 
Wednesday, January 17, 2024
Emerald, Mellanox Technologies, PCI Express, Fifth, NIC, TPM, SKU, SATA, Smart manufacturing, CRPS, Solid-state drive, 2.0, NVM Express, CPU, DDR5, Intel, Computer data storage

TAIPEI, Jan. 17, 2024 /PRNewswire/ -- AEWIN is glad to announce our latest High-Performance Network Appliance powered by Intel latest 5th Gen Xeon Scalable Processors, SCB-1942 Series.

Key Points: 
  • TAIPEI, Jan. 17, 2024 /PRNewswire/ -- AEWIN is glad to announce our latest High-Performance Network Appliance powered by Intel latest 5th Gen Xeon Scalable Processors, SCB-1942 Series.
  • It is a series of flagship products powered by dual Intel Emerald Rapids CPUs, having up to 128 CPU cores (64 cores per CPU) for the extreme computing power pursued in the market.
  • Furthermore, there are enhanced Intel® QuickAssist Technology (Intel® QAT) to accelerate data encryption and compression for secure content delivery.
  • Learn more about AEWIN SCB-1942 High-Performance Network Appliance:
    SCB-1942A : 2U Network Appliance with dual Intel 5th Gen Xeon Scalable Processors (Emerald Rapids-SP), total 8x PCIe Gen5 slots for NICs, Accelerators & NVMe SSDs
    SCB-1942C : 2U Edge Server with dual Intel 5th Gen Xeon Scalable Processors (Emerald Rapids-SP), 2x dual slot Gen5 x16 FHFL GPU cards, 4x PCIe Gen5 x8 slots for NICs, Accelerators & NVMe SSDs
    View original content to download multimedia: https://www.prnewswire.com/news-releases/aewin-scb-1942-flagship-applian...

SPR® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024

Retrieved on: 
Tuesday, January 16, 2024
Permanent, Sutter Health, Assistant, Hope, Patient, PNS, Therapy, Research, NANS, Knee, Medicare, Foot, Poster, Ankle, Groin, Section, Pain, SPRINT, NP-hardness, Shoulder, CRPS, SPR, Treatment, Abstract, Physician, Nursing

CLEVELAND, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. will be featured prominently at the North American Neuromodulation Society (NANS) Annual Meeting January 18-21 in Las Vegas.

Key Points: 
  • CLEVELAND, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. will be featured prominently at the North American Neuromodulation Society (NANS) Annual Meeting January 18-21 in Las Vegas.
  • A total of 11 abstracts highlighting applications of the SPRINT® PNS System will be featured at the meeting including four posters never before presented to the industry.
  • The presentation reviews treatment costs for patients in two cohorts who started treatment either with SPRINT PNS or with a conventional brief PNS trial.
  • The poster reviews health economics and outcomes research to explore the economic implications of the use of SPRINT PNS in chronic low back pain.

Center for Pain Management Expands Clinic in Lafayette, Indiana

Retrieved on: 
Tuesday, December 19, 2023
Patient, Neck pain, Pain management, Pain, Chronic pain, Society, CRPS, Accident, CFP, Neuropathic pain, Human, Public key certificate, Nursing

LAFAYETTE, Ind., Dec. 19, 2023 /PRNewswire/ -- Center for Pain Management (CFP) is excited to announce the expansion of its clinic in Lafayette, Indiana, doubling in size to allow the clinic to meet the pain needs of the Greater Lafayette area and surrounding communities.

Key Points: 
  • LAFAYETTE, Ind., Dec. 19, 2023 /PRNewswire/ -- Center for Pain Management (CFP) is excited to announce the expansion of its clinic in Lafayette, Indiana, doubling in size to allow the clinic to meet the pain needs of the Greater Lafayette area and surrounding communities.
  • Leading the Lafayette clinic is Dr. Joseph Rutledge, a highly qualified medical professional in Anesthesiology with specialized expertise in Pain Management.
  • Dr. Rutledge is fellowship trained and Board Certified by the American Board of Anesthesiology, with additional qualifications in Pain Management.
  • The newly expanded Lafayette clinic will provide a holistic approach to pain management, offering services such as minimally invasive procedures, physical therapy, and psychological support.

schuh launches Disability Equality tote bag with Shape Arts, inspired by 're-thinking disability'

Retrieved on: 
Thursday, November 16, 2023
Pillar, Health, Disability History Month, Amputation, Schuh, Culture, Disability, Shoe, Mental health, Shape Arts, Autism spectrum, Racial equality, CRPS, Health care, Pension fund

schuh shares the latest instalment of its charity tote bag series with Disability Equality partner, Shape Arts, designed by disability advocate and artist Grace Fairley .

Key Points: 
  • schuh shares the latest instalment of its charity tote bag series with Disability Equality partner, Shape Arts, designed by disability advocate and artist Grace Fairley .
  • The Purpose Pillars have evolved into three main pillars – Sustainability, Mental Wellness and Fostering Diverse Talent, which includes Racial Equality, Disability Equality and LGBT+ Equality.
  • Shape Arts nominated one of their artists, Grace Fairley, to create this year's tote bag design, inspired by the theme "re-thinking disability".
  • The Shape Arts x schuh tote bag will be available online and in stores this November, priced at £3.00/€3.44.

CGD Forms GaN Eco-System With Chicony Power and Cambridge University Technical Services

Retrieved on: 
Monday, November 6, 2023
Other Energy, Other Manufacturing, Hardware, Energy, Data Management, Technology, Semiconductor, Manufacturing, ESD, OCP, History, University of Cambridge, Research, CRPS, SMPS, HEMT, Gallium nitride, TWSE, TCAD, Electronics, AI, CGD, Silicon, CUTS, Video game

Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener electronics possible, has signed a tripartite agreement with Chicony Power Technology Co., Ltd (TWSE: 6412) of Taiwan and Cambridge University Technical Services (CUTS), UK, to conceive and develop advanced, efficient, high power-density adapters and data centre power products using GaN.

Key Points: 
  • Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener electronics possible, has signed a tripartite agreement with Chicony Power Technology Co., Ltd (TWSE: 6412) of Taiwan and Cambridge University Technical Services (CUTS), UK, to conceive and develop advanced, efficient, high power-density adapters and data centre power products using GaN.
  • Chicony Power is a well-established total solution provider of power electronics systems focusing on power supplies and adapters for various applications, including notebooks, desktop computers, gaming devices, and server/cloud solutions.
  • The HVMS group at Cambridge University has a history of 25 years in power device design, TCAD simulations and characterisation of power devices.
  • The three parties will collaborate around a technical project entitled ‘Innovative low power and high power SMPS (switch mode power supplies) with advanced GaN solutions’.

Medeloop Secures $8M Seed Funding to Pioneer the Future of Health Research

Retrieved on: 
Wednesday, September 20, 2023
Linda, Columbia University, Emeritus, Army, Genetics, Stanford University, LLM, EMR, PALO, Data collection, Hope, UCSD, Research, Agency for Healthcare Research and Quality, CRPS, Medicine, Doctor of Philosophy, Stanford University School of Medicine, UCSF, Investment, Patient, Bologna Business School, Diagnosis, AI, Ecosystem, McGill, Complex regional pain syndrome, Medical device, Nursing, Merck

To date, Medeloop has raised $10M in a year that will ensure continued expansion, key hires, and technological innovation.

Key Points: 
  • To date, Medeloop has raised $10M in a year that will ensure continued expansion, key hires, and technological innovation.
  • Medeloop’s AI-driven platform seamlessly integrates, harmonizes, and analyzes extensive health data using advanced AI tools that have the potential to significantly expedite the clinical research process.
  • "With an AI-driven approach, we believe Medeloop can accelerate breakthrough research to benefit patients," said Elena Viboch, Partner at General Catalyst, who will join the Medeloop board.
  • With innovative technology and a mission-focused approach, Medeloop holds the potential to transform healthcare research that can positively impact numerous patients.

CENTER FOR PAIN MANAGEMENT WELCOMES DR. JOSHUA WELLINGTON, MD.

Retrieved on: 
Friday, September 1, 2023
Spaulding Rehabilitation Hospital, Boston Children's Hospital, Intrathecal pump, Piriformis syndrome, Beth Israel Deaconess Medical Center, Neck pain, Arthralgia, Interventional pain management, Arthritis, Medical college, Therapy, Twilight anesthesia, ITP, Cancer, North American Neuromodulation Society, American Academy, CRPS, Medicine, MS, Harvard Medical School, Public key certificate, Back pain, Rehabilitation, Medical director, Patient, Physician, Practitioner, Physical medicine and rehabilitation, Fibromyalgia, Hospital, Health, NANS, Chronic pain, Headache, Society, Targeted drug delivery, Injury, Nursing, Dentistry, Pain management, MD

INDIANAPOLIS, Sept. 1, 2023 /PRNewswire/ -- Center for Pain Management, together with American Pain Consortium, a leading network of interventional pain practices, is pleased to announce that Joshua Wellington, MD, MS, has joined their practice and will be seeing patients starting September 5, 2023.

Key Points: 
  • INDIANAPOLIS, Sept. 1, 2023 /PRNewswire/ -- Center for Pain Management, together with American Pain Consortium, a leading network of interventional pain practices, is pleased to announce that Joshua Wellington, MD, MS, has joined their practice and will be seeing patients starting September 5, 2023.
  • He will be joining Center for Pain Management to lead the Targeted Drug Delivery program, which will expand patient access to quality care for Intrathecal Pump (ITP) implants.
  • Center for Pain Management, supported by American Pain Consortium, proudly serves Indiana with 7 clinics and 4 Ambulatory Surgery Centers statewide and has been treating a wide range of acute and chronic pain conditions since 1993.
  • The physicians specialize in back pain, neck pain, headache, and joint pain resulting from injuries, arthritis, cancer, fibromyalgia, failed back surgery, Complex Regional Pain Syndromes (CRPS), and other disorders.

JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain

Retrieved on: 
Tuesday, August 29, 2023
Hypersensitivity, Patent, Narcotic, CPRS, United States patent law, Endorphins, CRPS, Naltrexone, Today, Language, Pain, Report, Patient, Enkephalin, Janon, System, FDA, Chronic pain, Disease, Pharmaceutical industry

LAS VEGAS, Aug. 29, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), the visionary biotech company dedicated to discovering non-addictive treatments for pain, as well as causes of pain, has earned a US patent for its innovative formulation of low-dose naltrexone, Jan123, for treating pain.

Key Points: 
  • Jan123 is being developed to treat complex regional pain syndrome (CRPS), a rare and often life-altering condition characterized by severe pain and hypersensitivity to touch.
  • "Today, patients with complex regional pain syndrome must resort to long-term opioid and narcotics for relief," Isaac said.
  • Dr. Amol Soin, the inventor of Jan123 and its novel uses, expressed great satisfaction with the US Patent Office's action.
  • "All in all," CEO Isaac concluded, "this patent approval is an important milestone in our company's brief history—and a welcome confirmation of our strategic vision."